vTv Therapeutics (VTVT) FCF Margin (2014 - 2026)

vTv Therapeutics has disclosed FCF Margin across 11 years of filings, most recently posting 24.85% for Q1 2026.

• In Q1 2026, FCF Margin changed N/A year-over-year to 24.85%; the TTM figure through Jun 2026 stood at 45.34% (up 12876054.0% YoY), while the FY2024 annual figure was 2476.7%, changed N/A from the prior year.
• FCF Margin came in at 24.85% for Q1 2026 at vTv Therapeutics, up from 28200.0% in the prior quarter.
• In the past five years, FCF Margin ranged from a high of 7844.44% in Q2 2022 to a low of 76444.44% in Q4 2022.
• Average FCF Margin over 3 years is 16259.48%, with a median of 390.88% recorded in 2022.
• The largest YoY upside for FCF Margin was 5226667 bps in 2022 against a maximum downside of 514444 bps in 2022.
• Over 3 years, FCF Margin stood at 76444.44% in 2022, then jumped by 63 bps to 28200.0% in 2024, then soared by 100 bps to 24.85% in 2026.
• Per Business Quant data, the three most recent FCF Margin figures were 24.85% in Q1 2026, 28200.0% in Q4 2024, and 730.7% in Q1 2024.